0 13

Cited 1 times in

Cited 0 times in

Postdiagnosis physical activity is associated with improved survival in prostate cancer patients treated with surgery but not with radiation therapy

Authors
 An, Ki-Yong  ;  Jeon, Justin Y.  ;  Arthuso, Fernanda Z.  ;  Wang, Qinggang  ;  Friedenreich, Christine M.  ;  Courneya, Kerry S. 
Citation
 BRITISH JOURNAL OF CANCER, Vol.133(7) : 1029-1037, 2025-10 
Journal Title
BRITISH JOURNAL OF CANCER
ISSN
 0007-0920 
Issue Date
2025-10
Keywords
Aged ; Alberta ; Cohort Studies ; Disease-Free Survival ; Exercise* ; Humans ; Male ; Middle Aged ; Prostatectomy ; Prostatic Neoplasms* / diagnosis ; Prostatic Neoplasms* / mortality ; Prostatic Neoplasms* / radiotherapy ; Prostatic Neoplasms* / surgery ; Prostatic Neoplasms* / therapy
Abstract
BackgroundThe effects of exercise on cancer outcomes may differ depending on its positioning within different cancer treatment combinations. We examined whether the associations between physical activity (PA) and cancer outcomes varied by cancer treatment modality or timing of PA. MethodsWe conducted a secondary analysis of the Prostate Cancer Cohort Study consisting of 830 men in Alberta, Canada with newly diagnosed prostate cancer. Lifetime prediagnosis PA was assessed by an in-person interview shortly after diagnosis whereas postdiagnosis PA was assessed at 2-3 year intervals by an in-person interview (first follow-up) or self-report (second and third follow-ups). Cox proportional hazards regression models were used to test interactions between PA and treatment modalities for disease-free survival, overall survival, and prostate cancer-specific disease-free survival. ResultsPostdiagnosis vigorous PA significantly interacted with surgery (p < 0.001) and radiotherapy (p = 0.003). Specifically, patients who had surgery experienced a 61% lower likelihood of a disease-free survival event if they engaged in any versus no postdiagnosis vigorous PA (HR = 0.39, 95% CI = 0.27-0.57). Conversely, patients who received radiotherapy did not experience any benefit from postdiagnosis vigorous PA (HR = 1.14, 95% CI = 0.88-1.47). ConclusionsThe role of PA as a treatment for prostate cancer may depend on its combination and sequencing with other treatments.
DOI
10.1038/s41416-025-03123-0
Appears in Collections:
1. College of Medicine (의과대학) > Others (기타) > 1. Journal Papers
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/207346
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links